ArticleBiomedicines2025

Prognostic Significance of Delays in Initiation of Adjuvant Trastuzumab-Based Therapy in Patients with HER2-Positive Breast Cancer.

Gavin P Dowling et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.